Publications by authors named "Amber D P Doyle"

Claim this Profile
K
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies.
Lara V Graham, Jack G Fisher, Amber D P Doyle, Ben Sale, Luis Del Rio

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression.
Jack G Fisher, Amber D P Doyle, Lara V Graham, Shreyanshi Sonar, Ben Sale

Leukemia· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer.
Jack G Fisher, Amber D P Doyle, Lara V Graham, Salim I Khakoo, Matthew D Blunt

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.
Matthew D Blunt, Andres Vallejo Pulido, Jack G Fisher, Lara V Graham, Amber D P Doyle

J Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis